Optimizing Outcomes With Oral Antiplatelet Therapies

In this downloadable slideset, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
Format: Microsoft PowerPoint (.ppt)
File Size: 6.64 MB
Released: October 2, 2015

Acknowledgements

Supported by independent educational grants from
Daiichi Sankyo, Inc. and Lilly USA, LLC.
Merck & Co., Inc.

Related Content

Results from a recent subanalysis of the DAPT study have the potential to help clinicians address the challenging question of whether to extend DAPT duration for patients with coronary stents.

Christopher P. Cannon, MD Released: January 22, 2016

In this interactive presentation, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: October 2, 2015 Expiration: October 1, 2016

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?